Laddar...
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent for breast cancer. However, acquired chemoresistance leads to a loss of its efficacy; methods to reverse are urgently needed. Some studies have shown that pyrotinib, an ErbB receptor tyrosine kinase inhibitor, is effective against HER2(+)...
Sparad:
| I publikationen: | Oncol Res |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Cognizant Communication Corporation
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751227/ https://ncbi.nlm.nih.gov/pubmed/32727638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504020X15960154585410 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|